Increased circulating placental growth factor during percutaneous coronary intervention is associated with applied radiocontrast agent. [electronic resource]
Producer: 20090604Description: 130-7 p. digitalISSN:- 1473-5830
- Angina Pectoris -- blood
- Angioplasty, Balloon, Coronary
- Anticoagulants -- therapeutic use
- Biomarkers -- blood
- Case-Control Studies
- Cells, Cultured
- Contrast Media -- adverse effects
- Coronary Angiography
- Coronary Stenosis -- blood
- Dose-Response Relationship, Drug
- Endothelial Cells -- drug effects
- Heparin -- therapeutic use
- Humans
- Interleukin-6 -- blood
- Iopamidol -- adverse effects
- Myocardial Infarction -- blood
- Placenta Growth Factor
- Pregnancy Proteins -- blood
- Severity of Illness Index
- Time Factors
- Treatment Outcome
- Triiodobenzoic Acids -- adverse effects
- Up-Regulation
- Vascular Endothelial Growth Factor A -- blood
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.